The effect of genistein on the lipid compositions and sphingolipid metabolism has been investigated in A549 adenocarcinoma cells. The obtained results showed that sphingomyelin, phosphatidylserine and phosphatidylethanolamine were augmented, whereas phosphatidylcholine was reduced as a result of genistein treatment.
In order to reveal the mechanism underlying sphingomyelin elevation we analyzed two key sphingolipid-metabolizing enzymes, sphingomyelinase and ceramidase, which are responsible for maintenance of the major membrane sphingolipids. Both enzyme activities were reduced in genistein-treated A549 cells, which means that sphingomyelinase could be responsible for sphingomyelin augmentation. Noteworthy, the observed elevation of ceramide, which is recognized as marker of apoptosis, could be attributed to its decreased hydrolysis. The role of the “sphingolipid rheostat” in the balance between the pro-apoptotic effector ceramide and the pro-proliferative factor sphingosine-1-phosphate in genistein-treated lung carcinoma cells is discussed.
Key words: genistein, ceramide, lung carcinoma cells
Topic: BIOLOGY